These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24055412)

  • 61. Control of thrombocytosis by plateletpheresis using a cell separator.
    Beard ME; Blacklock HA; Varcoe AR
    N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Use of plateletpheresis in the treatment of bronchial asthma].
    Tatarskiĭ AR; Emirova AS; Bobkov EV; Chuchalin AG
    Ter Arkh; 1991; 63(3):90-3. PubMed ID: 2063345
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Platelet concentrates, from whole blood or collected by apheresis?
    van der Meer PF
    Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil-platelet aggregates.
    Stohlawetz P; Kapiotis S; Seidl D; Hergovich N; Zellner M; Eichler HG; Stiegler G; Leitner G; Höcker P; Jilma B
    Transfusion; 1999 Apr; 39(4):420-7. PubMed ID: 10220271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.
    Heuft HG; Moog R; Fischer EG; Zingsem J;
    Transfusion; 2013 Jan; 53(1):211-20. PubMed ID: 22612302
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor.
    Weibrich G; Kleis WK; Kunz-Kostomanolakis M; Loos AH; Wagner W
    Int J Oral Maxillofac Implants; 2001; 16(5):693-9. PubMed ID: 11669252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Use of a freshly prepared thrombocyte mass in thrombocytopenic hemorrhages].
    Baĭdurin SA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):33-9. PubMed ID: 7367409
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study.
    Feng Q; Zhu F; Li C; Guo B; Ye J; Chen J
    Indian J Hematol Blood Transfus; 2019 Oct; 35(4):736-741. PubMed ID: 31741630
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of plateletpheresis on the white blood cell count: meta-analysis 1980-2018].
    Gil-Betacur A; Mantilla-Gutierrez CY; Cardona-Arias JA
    Rev Esp Salud Publica; 2019 Sep; 93():. PubMed ID: 31537778
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fresh frozen plasma quality: relation to age and gender of blood donors.
    Madla W; Alt T; Jungk H; Bux J
    Vox Sang; 2012 Feb; 102(2):116-24. PubMed ID: 21752027
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Repeat plateletpheresis--the effects on the donor and the yield.
    Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
    Prog Clin Biol Res; 1990; 337():27-30. PubMed ID: 2352986
    [No Abstract]   [Full Text] [Related]  

  • 76. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
    Alex J; Roberts B; Raife T
    J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute myocardial infarction secondary to platelet apheresis in a 57-year healthy donor.
    Rosencher J; Zuily S; Varenne O; Spaulding C; Weber S
    Int J Cardiol; 2011 Aug; 150(3):e119-20. PubMed ID: 20236712
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A model to determine required pool size for HLA-typed community donor apheresis programs.
    Bolgiano DC; Larson EB; Slichter SJ
    Transfusion; 1989 May; 29(4):306-10. PubMed ID: 2718233
    [TBL] [Abstract][Full Text] [Related]  

  • 79. COVID-19 vaccine humoral response in frequent platelet donors with plateletpheresis-associated lymphopenia.
    Laumaea AE; Lewin A; Chatterjee D; Marchitto L; Ding S; Gendron-Lepage G; Goyette G; Allard MÈ; Simard C; Tremblay T; Perreault J; Duerr R; Finzi A; Bazin R
    Transfusion; 2022 Sep; 62(9):1779-1790. PubMed ID: 35919021
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of plateletpheresis on hematocrit, hemoglobin and erythrocyte count: Meta-analysis 1980-2018.
    Gil-Betacur A; Mantilla-Gutiérrez CY; Cardona-Arias JA
    Sci Rep; 2019 Dec; 9(1):19770. PubMed ID: 31875045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.